On the other hand, other studies have found that high levels of SIRT1 can inhibit tumorigenesis in BRCA-1 BC, which is usually a type of TNBC, and it is the phenotype of the MDA-MB-231 cell line, presenting higher levels of p53 mutations [62,63]. Here, SIRT1 is linked to invasive breast carcinoma.